Results 261 to 270 of about 2,458,624 (375)

Evaluating a mobile app's effects on depression and anxiety in medication-treated opioid use disorder. [PDF]

Npj Ment Health Res
Heinz MV, Lekkas D, Abreu V, Lee C, Marsch LA, Jacobson NC.   +5 more
europepmc   +1 more source

Postpartum medication for opioid use disorder outcomes associated with prenatal treatment and neighborhood-level social determinants. [PDF]

Am J Obstet Gynecol MFM, 2023
Martin CE, Britton E, Shadowen H, Johnson J, Sabo R, Cunningham P.   +5 more
europepmc   +1 more source

Medication Utilization Among Children With Sickle Cell Disease in the United States

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Objective The medication management of children with sickle cell disease (SCD), especially since the release of the 2014 National Heart, Lung, and Blood Institute (NHLBI) SCD treatment guidelines, is not well described in the published literature.
Abiodun John Ologunowa, Kelly L. Matson, Jung Eun Lee, Meghan McCormick, Mary L. Greaney, Aisling R. Caffrey   +5 more
wiley   +1 more source

HIV and Hepatitis C Virus Testing and Treatment Services in Specialty Treatment Facilities That Offer Medication for Opioid Use Disorder in the US

, 2022
Eshan U. Patel, Becky L. Genberg, Xianming Zhu, Noa Krawczyk, Shruti H. Mehta, Aaron A.R. Tobian   +5 more
openalex   +2 more sources

Immediate Effects of Mindful Awareness in Body-Oriented Therapy as an Adjunct to Medication for Opioid Use Disorder. [PDF]

Mindfulness (N Y)
Price CJ, Pike KC, Treadway A, Palmer JK, Merrill JO.   +4 more
europepmc   +1 more source

Perceptions of COVID-19 risk during the pandemic: perspectives from people seeking medication for opioid use disorder. [PDF]

Ann Med, 2023
Clingan SE, Cousins SJ, Lin C, Nguyen TE, Hser YI, Mooney LJ.   +5 more
europepmc   +1 more source

Relationship of the revised anticholinergic drug scale with cultured cell‐based serum anticholinergic activity and cognitive measures in older adults with mild cognitive impairment or remitted depression

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, EarlyView.
Abstract Objective The Anticholinergic Drug Scale (ADS) is a commonly used measure of anticholinergic exposure. This study describes an expanded and revised version of the ADS (rADS) and its relationship with cultured cell‐based serum anticholinergic activity (cSAA) and cognitive measures.
Ryan M. Carnahan, Susmita Chandramouleeshwaran, Naba Ahsan, Roger Raymond, Jose N. Nobrega, Wei Wang, Corinne E. Fischer, Alastair J. Flint, Nathan Herrmann, Sanjeev Kumar, Krista L. Lanctôt, Linda Mah, Benoit H. Mulsant, Bruce G. Pollock, Tarek K. Rajji   +14 more
wiley   +1 more source

Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19

, 2022
Melissa N. Poulsen, William Santoro, Roseanne Scotti, Catherine Henderson, Meaghan Ruddy, Angela Colistra   +5 more
openalex   +2 more sources

Corrigendum to "Receipt of medication for opioid use disorder among rural and urban veterans health administration patients" [Drug Alcohol Depend. Rep. 14 (2025) 100311]. [PDF]

Drug Alcohol Depend Rep
Reynolds OC, Carlson KF, Gordon AJ, Handley RL, Morasco BJ, Korthuis TP, Lovejoy TI, Wyse JJ.   +7 more
europepmc   +1 more source

Treatment Initiation, Substance Use Trajectories, and the Social Determinants of Health in Persons Living With HIV Seeking Medication for Opioid Use Disorder. [PDF]

Subst Abus, 2023
Cook RR, Jaworski EN, Hoffman KA, Waddell EN, Myers R, Korthuis PT, Vergara-Rodriguez P.   +6 more
europepmc   +1 more source